Table 1 Objectives and instrumental set-up of the trial
| Â | Variable | Instrument |
|---|---|---|
Primary objective | Behavioural and psychological symptoms (BPSD) | Alzheimer’s Disease Cooperative Study-Clinical Global Impression of Change [33] |
Secondary objective | Dimensions of BPSD | Neuropsychiatric Inventory (NPI) [35] |
| Â | Â | Cohen-Mansfield-Agitation-Inventory [36] |
| Â | Caregiver burden | NPI-caregiver-subscale [35] |
| Â | Application of antipsychotics | Chlorpromazine-equivalents [34] |
| Â | Application of benzodiazepine | Diazepam-equivalents [36] |
| Â | Motor behaviour | Body fixed motion sensor |
| Â | Saliva cortisol levels | Demeditecâ„¢ saliva kits [42] |
| Â | Neurotrophic factor levels | Brain-derived neurotrophic factor from blood-serum probes [44] |